Press release
Hepatitis C Treatment Market to Exceed US$ 71.13 Bn in 2024
Request to Sample of Report @ https://www.persistencemarketresearch.com/samples/3602
Market dynamics
Growth of the global hepatitis C treatment market is primarily driven by factors such as increase in the prevalence of hepatitis C infections in the U.S. and Canada and rising per capita healthcare expenditure across the globe. Also government initiatives to control infection and various private NGOs creating awareness about treatment is also fueling the market growth. However, high cost associated with hepatitis C treatment drugs and lack of awareness about hepatitis C infection in the regions of Asia Pacific, Middle East and Africa, and Latin America is expected to impede growth of the global hepatitis C treatment market.
Request Report Multiple Chapter @ https://www.persistencemarketresearch.com/multiple-chapter/3602
Market forecast
By drug class, the market is segmented into HCV Protease Inhibitors, HCV Polymerase Inhibitors, HCV NS5A Inhibitors, Combination Therapy and Interferon & Antiviral which is again sub-divided into various drugs sub segments. The combination segment is expected to contribute a maximum share to the global hepatitis C treatment market and register the fastest CAGR of 13.9% during the forecast period. By distribution channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies and Online Pharmacies. Among these, the hospital pharmacies segment is anticipated to be dominant throughout the forecast period and is projected to account for about 43.7% share of the total global hepatitis C treatment market revenue by 2024. The hospital pharmacies segment is anticipated to emerge as the most attractive segment in the global hepatitis C treatment market owing to growing instances of hospitalization and improved accessibility and services. The online pharmacies segment is expected to register the fastest CAGR during the forecast period and is estimated to create absolute $ opportunity of US$ 713.8 Mn in 2017 over 2016. The online pharmacies segment is expected to witness significant growth during the forecast period and this can be attributed to high availability of hepatitis C treatment drugs and discounts provided by online pharmacies.
This report covers global and regional trends along with an analysis of the market potential. North America is estimated to account for 45% share in the global hepatitis C treatment market by 2016, whereas Asia Pacific is projected to grow at a healthy CAGR of 14.8% due to increasing awareness about hepatitis C infections. Europe region is expected to account for 19.6% share in the global hepatitis C treatment market by 2016 end. Latin America was valued at US$ 2,915.8 Mn in 2015 and is estimated to reach US$ 3,311.1 Mn by 2016, with a Y-o-Y growth of 13.6% over 2015–2016. The Middle East and Africa region was valued at US$ 1,792.5 Mn in 2015 and is estimated to reach US$ 1,988.1 Mn by 2016.
For more information @ https://www.prnewswire.com/news-releases/global-hepatitis-c-treatment-market-to-reach-us-7113-bn-by-2024---persistence-market-research-603758106.html
Competitive landscape
The global hepatitis C treatment market report features some of the top companies dominating in the global market. Key market players analyzed in the report include Merck & Co., Inc., Bristol-Myers Squibb Company, AbbVie Inc., Gilead Sciences, Inc., Kadmon Holdings, Inc., Johnson & Johnson, F Hoffmann-La Roche Ltd, and Merck & Co., Inc. Leading companies functioning in the global hepatitis C treatment market are focusing on collaborating with healthcare solutions and services providers in order to advance operational efficiencies and provide improved patient care.
Get full report now @ https://www.persistencemarketresearch.com/checkout/3602
About Us
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Hepatitis C Treatment Market to Exceed US$ 71.13 Bn in 2024 here
News-ID: 1041589 • Views: …
More Releases from Persistence Market Research pvt ltd
Rise of Cloud Computing and Big Data Analytics Drives Processor Market Growth to …
According to a recent report by Persistence Market Research, the global processor market is expected to reach a value of US$ 332.0 billion by 2033, growing at a CAGR of approximately 9.6% during the forecast period.
The increasing demand for processors in smartphones, tablets, and other mobile devices is a key driver of market growth. The report also notes that the demand for processors in the automotive industry is expected…
Building Products Market Expected to Grow at 5.2% CAGR to Reach USD 1.5 Trillion …
the global building products market size was valued at USD 1.1 trillion and is expected to reach USD 1.5 trillion by 2026, growing at a CAGR of 5.2% during the forecast period.
The building products market encompasses a wide range of products used in the construction and renovation of residential, commercial, and industrial buildings. These products include but are not limited to lumber and wood products, roofing materials, insulation, windows and…
Road Sweeping Machine Market Size to Surpass US$ 5.9 billion by 2028 | Persisten …
Road Sweeping Machine Market
The global road sweeping machine market is expected to reach a value of US$ 5.9 billion by 2028, growing at a CAGR of 6.5% from 2023 to 2028. The market growth is driven by several factors such as urbanization, increasing infrastructure development, rising awareness about environmental cleanliness, and government initiatives to promote sustainable living.
Click Here to Get Free Sample Copy of this Report @https://www.persistencemarketresearch.com/samples/16750
Road sweeping machines are…
Pigments & Dyes Market is expected to grow at a CAGR of 4.3% from 2023 to 2028
Pigments & Dyes Market
The global pigments and dyes market was valued at US$ 27.8 billion in 2022 and is expected to grow at a CAGR of 4.3% from 2022 to 2028, according to a report by PMR. The growth in the market can be attributed to the increasing demand for pigments and dyes from end-use industries such as textiles, paints, coatings, and plastics. The demand for high-performance pigments and dyes…
More Releases for Hepatitis
Is Hepatitis A Vaccine Required?
Hepatitis A Vaccine Market describes its growth, size, share, Forecast and trends to 2025
Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year.
Two types of HAV vaccines are currently available internationally:
1. Formaldehyde-inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available…
Hepatitis Drugs Market Is Growing Due to Increasing R&D Investments on Hepatitis …
The global hepatitis drugs market is growing due to increasing incidences of hepatitis and increasing support from government organizations. In addition, the growing geriatric population, and increasing R&D investments on hepatitis research and drug discovery are also driving the growth of the global hepatitis drugs market.
Access Detailed Report Summary: https://www.psmarketresearch.com/market-analysis/hepatitis-drugs-market
Among the various types, the hepatitis C segment is expected to be the largest segment, and expected to witness the fastest…
Hepatitis B Therapeutics Market Is Driven by Rising Incidence of Hepatitis B In …
Hepatitis B is a life threatening liver infection caused by hepatitis B virus. Adults who get affected by hepatitis B virus for a short time and then get cured is known as acute hepatitis B. Infection that lasts for a long time is known as chronic hepatitis B. Vaccine is the most preferred choice of doctors and physicians to protect people from the disease. The vaccine prevents the infection and…
Hepatitis E Hyperendemicity to Drive Hepatitis E Diagnostic Tests Market Growth
Global Hepatitis E Diagnostic Tests Market: Snapshot
The growing incidence of hepatitis E, a liver disease caused by infection due to the virus hepatitis E virus (HEV), is a leading cause of morbidity and mortality worldwide. There is increasing prevalence of hepatitis E in resource-limited region, such as various countries of Asia Pacific. The people of these regions suffer with frequent water contamination and have limited access to sanitation and hygiene,…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
Hepatitis C Drug Pipeline Analysis
“Hepatitis C Drug Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various drug profiles being developed for the treatment of Hepatitis C. Research report covers all the ongoing drug development in various phases. Each drug profiles include detailed information like: Originator, Owner, Collaborator, Technology Provider, Licensee, Development Phase, Development Indications, Mechanism of Action, Chemical Formula, Country of Development and detailed analysis on the development process. Insight for each…
